Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

OmniAb, Inc. Warrant (OABIW)

Services-commercial Physical & Biological Research

https://www.omniab.com

OmniAb Inc offers therapeutic antibody discovery technologies. Its focus is to enable the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully-human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

5980 HORTON STREET, SUITE 600
EMERYVILLE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/01/2022

Market Cap

471,575,132

Shares Outstanding

116,230,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

2.0952

Last Div

0.0000

Range

0.4222-0.4222

Chg

0.0032

Avg Vol

N/A

Mkt Cap

471575132

Exch

NASDAQ

Country

US

Phone

510 250 7800

DCF Diff

9.1660

DCF

-4.5772

Div Yield

0.0000

P/S

22.6280

EV Multiple

-7.7957

P/FV

1.4468

Div Yield %

0.0000

P/E

-6.8225

PEG

-0.2619

Payout

0.0000

Current Ratio

4.7550

Quick Ratio

4.7550

Cash Ratio

1.4691

DSO

115.5817

DIO

0.0000

Op Cycle

115.5817

DPO

49.2263

CCC

66.3554

Gross Margin

0.0408

Op Margin

-3.8161

Pretax Margin

-3.5082

Net Margin

-2.8729

Eff Tax Rate

0.1811

ROA

-0.1850

ROE

-0.2021

ROCE

-0.2565

NI/EBT

0.8189

EBT/EBIT

0.9193

EBIT/Rev

-3.8161

Debt Ratio

0.0721

D/E

0.0827

LT Debt/Cap

0.0660

Total Debt/Cap

0.0764

Int Coverage

0.0000

CF/Debt

-1.8302

Equity Multi

1.1464

Rec Turnover

3.1579

Pay Turnover

7.4147

Inv Turnover

0.0000

FA Turnover

0.5998

Asset Turnover

0.0644

OCF/Share

-0.4389

FCF/Share

-0.4614

Cash/Share

0.5641

OCF/Sales

-2.0509

FCF/OCF

1.0511

CF Coverage

-1.8302

ST Coverage

-12.5198

CapEx Coverage

-19.5836

Div&CapEx Cov

-19.5836

P/BV

1.4468

P/B

1.4468

P/S

22.6280

P/E

-6.8225

P/FCF

-10.4972

P/OCF

-9.5571

P/CF

-9.5571

PEG

-0.2619

P/S

22.6280

EV Multiple

-7.7957

P/FV

1.4468

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation